BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33614284)

  • 21. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma.
    Mei Y; Lv Q; Tan Z; Zhang Z; Ji Y; Chen S; Shen X
    Biotechnol Genet Eng Rev; 2023 May; ():1-22. PubMed ID: 37191010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways.
    Wang X; Zeng Y; Zhou M; Zhang X; Xu A; Lin J; Wu Z; Xie C; Luo J; Ding S; Zhan Z; Long H; Song Y
    Cancer Cell Int; 2019; 19():324. PubMed ID: 31827398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of
    Yu Z; Liu Z; Lian X; Cheng X; Liu B; Zhang B; Wang H; Wang J; Li A; Ren Z; Pang B; Qian R; Gao Y
    Cell Cycle; 2022 Nov; 21(22):2387-2402. PubMed ID: 35852388
    [No Abstract]   [Full Text] [Related]  

  • 25. Stanniocalcin 1 is a prognostic biomarker in glioma.
    Luo W; Chen D; Wang H; Hu J
    Oncol Lett; 2020 Sep; 20(3):2248-2256. PubMed ID: 32782542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma.
    Chen Y; Tang M; Xiong J; Gao Q; Cao W; Huang J
    Cancer Cell Int; 2022 Jul; 22(1):223. PubMed ID: 35790975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas.
    Zhou J; Xing Z; Xiao Y; Li M; Li X; Wang D; Dong Z
    Front Mol Biosci; 2022; 9():816939. PubMed ID: 35547391
    [No Abstract]   [Full Text] [Related]  

  • 29. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
    Liu Z; Zhang W; Cheng X; Wang H; Bian L; Wang J; Han Z; Wang Y; Lian X; Liu B; Ren Z; Zhang B; Jiang Z; Lin Z; Gao Y
    Mol Med; 2021 May; 27(1):52. PubMed ID: 34051735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma.
    Wang X; Yang Q; Liu N; Bian Q; Gao M; Hou X
    Pathol Oncol Res; 2021; 27():1609825. PubMed ID: 34629960
    [No Abstract]   [Full Text] [Related]  

  • 31. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
    Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
    Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
    Yang G; Tang S; Zhang J; Qin L
    World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and Prognostic Role of PLOD1 in Malignant Glioma.
    Wang H; Luo W; Dai L
    Onco Targets Ther; 2020; 13():13285-13297. PubMed ID: 33402837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma.
    Liu J; Gao L; Liao J; Yang J; Yuan F; Chen Q
    Ann Transl Med; 2021 Feb; 9(3):260. PubMed ID: 33708887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
    Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
    PeerJ; 2021; 9():e11422. PubMed ID: 34040895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma.
    Zhang W; Liu Z; Liu B; Jiang M; Yan S; Han X; Shen H; Na M; Wang Y; Ren Z; Liu B; Jiang Z; Gao Y; Lin Z
    Cancer Cell Int; 2021 Jun; 21(1):297. PubMed ID: 34098960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitro.
    Zhang W; Blank A; Kremenetskaia I; Nitzsche A; Acker G; Vajkoczy P; Brandenburg S
    BMC Cancer; 2024 Mar; 24(1):369. PubMed ID: 38519889
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Liu Z; Ren Z; Zhang C; Qian R; Wang H; Wang J; Zhang W; Liu B; Lian X; Wang Y; Guo Y; Gao Y
    Front Oncol; 2021; 11():608748. PubMed ID: 34976781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
    Yao J; Chen X; Liu Z; Zhang R; Zhang C; Yang Q; Yao P; Jiang Q; Wu J; Zhao S
    Chin Neurosurg J; 2021 Mar; 7(1):21. PubMed ID: 33750478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.